STOCK TITAN
  1. Home
  2. Sec-filings
  3. SENS
  4. [Form 4] Senseonics Holdings, Inc. Insider Trading Activity

Senseonics (SENS) CMO granted 63,177 RSUs and options on 86,935 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Senseonics Holdings, Inc. reported that Chief Medical Officer Francine Kaufman received equity-based compensation on May 19, 2026. She was granted 63,177 restricted stock units, each representing a contingent right to one share of common stock. Following this grant, she holds 181,067 common shares directly.

She was also awarded an employee stock option for 86,935 shares of common stock at an exercise price of $5.54 per share, expiring on May 18, 2036. The RSUs vest in eight equal installments beginning June 15, 2026, while the options vest in 48 equal monthly installments starting May 19, 2026, in each case subject to her continued service.

Positive

  • None.

Negative

  • None.
Insider Kaufman Francine
Role Chief Medical Officer
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) 86,935 $0.00 --
Grant/Award Common Stock 63,177 $0.00 --
Holdings After Transaction: Employee Stock Option (right to buy) — 86,935 shares (Direct, null); Common Stock — 181,067 shares (Direct, null)
Footnotes (1)
  1. Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2026 and the remaining seven installments vesting in six month increments commencing on November 15, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The options vest in 48 equal monthly installments commencing on May 19, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
RSU grant size 63,177 units Each RSU equals one share of common stock
Shares held after RSU grant 181,067 shares Common stock directly owned after non-derivative transaction
Option grant size 86,935 options Employee stock option for common stock
Option exercise price $5.54 per share Conversion or exercise price of employee stock option
Option expiration May 18, 2036 Expiration date of employee stock option grant
RSU vesting start June 15, 2026 First of eight equal RSU vesting installments
Option vesting start May 19, 2026 First of 48 equal monthly option vesting installments
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") grant."
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy) with underlying common stock."
vesting financial
"The RSUs vest in eight equal installments with the first installment vesting on June 15, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kaufman Francine
(Last)(First)(Middle)
20451 SENECA MEADOWS PARKWAY
(Street)
GERMANTOWN MARYLAND 20876
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Senseonics Holdings, Inc. [ SENS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A63,177(1)A$0(2)181,067D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$5.5405/19/2026A86,935 (3)05/18/2036Common Stock86,935$086,935D
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2026 and the remaining seven installments vesting in six month increments commencing on November 15, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
3. The options vest in 48 equal monthly installments commencing on May 19, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
/s/ Frederick T. Sullivan, Attorney-in-Fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did SENS Chief Medical Officer Francine Kaufman report?

Francine Kaufman reported equity awards, not open-market trades. She received 63,177 restricted stock units and an option for 86,935 shares, both as compensation awards that vest over time, subject to her continued service with Senseonics Holdings.

How many Senseonics (SENS) shares does Francine Kaufman hold after this Form 4?

After the restricted stock unit grant, Francine Kaufman directly holds 181,067 shares of Senseonics common stock. This figure reflects only the non-derivative holdings reported and does not include unexercised options, which are disclosed separately in the derivative transaction record.

What are the key terms of Francine Kaufman’s RSU grant at Senseonics (SENS)?

Kaufman’s RSU grant covers 63,177 units, each equal to one share of common stock. The RSUs vest in eight equal instalments starting June 15, 2026, then every six months through November 15, 2029, provided she remains in continuous service with the company.

What are the terms of the employee stock option granted to Francine Kaufman by SENS?

She received an employee stock option for 86,935 shares of Senseonics common stock with a $5.54 exercise price. The option vests in 48 equal monthly installments beginning May 19, 2026 and expires on May 18, 2036, assuming continued service through each vesting date.

Is Francine Kaufman’s Form 4 for SENS a stock purchase or sale?

The Form 4 reflects equity awards, not market purchases or sales. Both reported transactions use code “A,” indicating grants or awards of RSUs and stock options as compensation. No open-market buy or sell transactions were reported in this filing.

How do the RSU and option vesting schedules work for SENS Chief Medical Officer?

The RSUs vest in eight equal tranches from June 15, 2026, then every six months. The options vest monthly over 48 months starting May 19, 2026. In both cases, vesting requires Francine Kaufman to remain in continuous service with Senseonics Holdings.